Skip to content
Collegium Pharmaceutical
Medical Affairs
Mobile Menu Toggle navigation
Collegium Pharmaceutical
Medical Affairs
  • Resources
    • Resources
    • Upcoming Meetings
  • Medical Information
  • Education
  • Request a Follow-Up
  • Keep Me Updated
  • Resources
    • Resources
    • Upcoming Meetings
  • Medical Information
  • Education
  • Request a Follow-Up
  • Keep Me Updated
Collegium Pharmaceutical
  • Resources
    • Resources
    • Upcoming Meetings
  • Medical Information
  • Education
  • Request a Follow-Up
  • Keep Me Updated

Nelson T, Brett V. Tapentadol: an initial analysis–follow-up. J Opioid Manag. 2011;7(2):87-92.

Post navigation

The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (?-opioid receptor) knockout mice
Tapentadol in pain management: a ?-opioid receptor agonist and noradrenaline reuptake inhibitor

Leave a Reply Cancel reply

You must be logged in to post a comment.

Collegium Pharmaceutical
  • info@collegiumpharma.com
  • (781) 713-3699
  • Privacy Policy
  • Terms of Use
  • Site Credits

© 2023